20052019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019

The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries

Laitman, Y., Friebel, T. M., Yannoukakos, D., Fostira, F., Konstantopoulou, I., Figlioli, G., Bonanni, B., Manoukian, S., Zuradelli, M., Tondini, C., Pasini, B., Peterlongo, P., Plaseska-Karanfilska, D., Jakimovska, M., Majidzadeh, K., Zarinfam, S., Loizidou, M. A., Hadjisavvas, A., Michailidou, K., Kyriacou, K. & 16 others, Behar, D. M., Molho, R. B., Ganz, P., James, P., Parsons, M. T., Sallam, A., Olopade, O. I., Seth, A., Chenevix - Trench, G., Leslie, G., McGuffog, L., Marafie, M. J., Megarbane, A., Al-Mulla, F., Rebbeck, T. R. & Friedman, E., Nov 1 2019, In : Human Mutation. 40, 11, p. e1-e23

Research output: Contribution to journalArticle

The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries

Laitman, Y., Friebel, T. M., Yannoukakos, D., Fostira, F., Konstantopoulou, I., Figlioli, G., Bonanni, B., Manoukian, S., Zuradelli, M., Tondini, C., Pasini, B., Peterlongo, P., Plaseska-Karanfilska, D., Jakimovska, M., Majidzadeh, K., Zarinfam, S., Loizidou, M. A., Hadjisavvas, A., Michailidou, K., Kyriacou, K. & 16 others, Behar, D. M., Molho, R. B., Ganz, P., James, P., Parsons, M. T., Sallam, A., Olopade, O. I., Seth, A., Chenevix - Trench, G., Leslie, G., McGuffog, L., Marafie, M. J., Megarbane, A., Al-Mulla, F., Rebbeck, T. R. & Friedman, E., Nov 1 2019, In : Human Mutation. 40, 11, p. e1-e23

Research output: Contribution to journalArticle

The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries: Human Mutation

Laitman, Y., Friebel, T. M., Yannoukakos, D., Fostira, F., Konstantopoulou, I., Figlioli, G., Bonanni, B., Manoukian, S., Zuradelli, M., Tondini, C., Pasini, B., Peterlongo, P., Plaseska-Karanfilska, D., Jakimovska, M., Majidzadeh, K., Zarinfam, S., Loizidou, M. A., Hadjisavvas, A., Michailidou, K., Kyriacou, K. & 16 others, Behar, D. M., Molho, R. B., Ganz, P., James, P., Parsons, M. T., Sallam, A., Olopade, O. I., Seth, A., Chenevix - Trench, G., Leslie, G., McGuffog, L., Marafie, M. J., Megarbane, A., Al-Mulla, F., Rebbeck, T. R. & Friedman, E., 2019, In : Hum. Mutat.. 40, 11, p. e1-e23

Research output: Contribution to journalArticle

2018

Never too old to fight breast cancer: A case report

Zuradelli, M., Masci, G., Ferraro, E., Losurdo, A., De Sanctis, R., Torrisi, R. & Santoro, A., Mar 2018, In : Medicine. 97, 9, p. e9981

Research output: Contribution to journalArticle

2016

Aromatase inhibitors in premenopause: Great expectations fulfilled?

Torrisi, R. M. C., Rota, S., Losurdo, A., Zuradelli, M., Masci, G. & Santoro, A., Nov 2016, In : Critical Reviews in Oncology/Hematology. 107, p. 82-89 8 p.

Research output: Contribution to journalArticle

2015

Clinicopathological and immunohistochemical characteristics in male breast cancer: A retrospective case series

Masci, G., Caruso, M., Caruso, F., Salvini, P., Carnaghi, C., Giordano, L., Miserocchi, V., Losurdo, A., Zuradelli, M., Torrisi, R., Tommaso, L. D., Tinterri, C., Testori, A., Garcia-Etienne, C. A., Gatzemeier, W. & Santoro, A., 2015, In : The oncologist. 20, 6, p. 586-592 7 p.

Research output: Contribution to journalArticle

2013

Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom control.

La Verde, N., Moretti, A., Farina, G., Dazzani, M. C., Gamucci, T., Borgonovo, K., Botta, M., Salesi, N., Zuradelli, M., Pavese, I., Barbieri, E., Cretella, E., Saladino, T., Varese, P., Traverso, E. S., Addamo, G., Ciccarese, M., Rispoli, A. I., Pellegrino, A., Mentuccia, L. & 3 others, Girelli, S., Piva, S. & Di Maio, M., Dec 2013, In : Future Oncology. 9, 12, p. 1841-1848 8 p.

Research output: Contribution to journalArticle

Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy

Gullo, G., Bettio, D., Zuradelli, M., Masci, G., Giordano, L., Bareggi, C., Tomirotti, M., Salvini, P., Runza, L., La Verde, N. & Santoro, A., Apr 2013, In : Breast. 22, 2, p. 190-193 4 p.

Research output: Contribution to journalArticle

Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: A retrospective study in a sample of Italian cancer genetics clinics

Varesco, L., Viassolo, V., Viel, A., Gismondi, V., Radice, P., Montagna, M., Alducci, E., Della Puppa, L., Oliani, C., Tommasi, S., Caligo, M. A., Vivanet, C., Zuradelli, M., Mandich, P., Tibiletti, M. G., Cavalli, P., Lucci Cordisco, E., Turchetti, D., Boggiani, D., Bracci, R. & 2 others, Bruzzi, P. & Bonelli, L., Dec 2013, In : Breast. 22, 6, p. 1130-1135 6 p.

Research output: Contribution to journalArticle

Phase i pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

Simonelli, M., Zucali, P. A., Lorenzi, E., Rubino, L., De Vincenzo, F., De Sanctis, R., Perrino, M., Mancini, L., Di Tommaso, L., Rimassa, L., Masci, G., Zuradelli, M., Suter, M. B., Bertossi, M., Fattuzzo, G., Giordano, L., Roncalli, M. G. & Santoro, A., Mar 2013, In : European Journal of Cancer. 49, 5, p. 989-998 10 p.

Research output: Contribution to journalArticle

Potential impact of the 70-gene signature in the choice of adjuvant systemic treatment for ER positive, HER2 negative tumors: A single institution experience

Torrisi, R., Garcia-Etienne, C. A., Losurdo, A., Morenghi, E., Di Tommaso, L., Gatzemeier, W., Sagona, A., Fernandes, B., Rossetti, C., Eboli, M., Rubino, A., Barbieri, E., Andreoli, C., Orefice, S., Gandini, C., Rota, S., Zuradelli, M., Masci, G., Santoro, A. & Tinterri, C., Aug 2013, In : Breast. 22, 4, p. 419-424 6 p.

Research output: Contribution to journalArticle

Weekly non-pegylated liposomal doxorubicin chemotherapy in heavily pre-treated patients with metastatic breast cancer

Masci, G., Gandini, C., Zuradelli, M., Losurdo, A., Torrisi, R., Rota, S., Gullo, G., Velutti, L., Giordano, L. & Santoro, A., Oct 2013, In : Anticancer Research. 33, 10, p. 4603-4610 8 p.

Research output: Contribution to journalArticle

2012

Durable complete response following chemotherapy and trastuzumab for metastatic her2-positive breast cancer

Gullo, G., Zuradelli, M., Sclafani, F., Santoro, A. & Crown, J., Aug 2012, In : Annals of Oncology. 23, 8, p. 2204-2205 2 p., mds221.

Research output: Contribution to journalArticle

2011

Fulvestrant for advanced male breast cancer patients: A case series

Masci, G., Gandini, C., Zuradelli, M., Pedrazzoli, P., Torrisi, R., Lutman, F. R. & Santoro, A., 2011, In : Annals of Oncology. 22, 4, p. 985 1 p.

Research output: Contribution to journalArticle

2010

Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: Clinical, pathological, and family characteristics

Zuradelli, M., Peissel, B., Manoukian, S., Zaffaroni, D., Barile, M., Pensotti, V., Cavallari, U., Masci, G., Mariette, F., Benski, A. C., Santoro, A. & Radice, P., Nov 2010, In : Breast Cancer Research and Treatment. 124, 1, p. 251-258 8 p.

Research output: Contribution to journalArticle

2009

High incidence of hypocalcemia and serum creatinine increase in patients with bone metastases treated with zoledronic acid

Zuradelli, M., Masci, G., Biancofiore, G., Gullo, G., Scorsetti, M., Navarria, P., Tancioni, F., Berlusconi, M., Giordano, L. & Santoro, A., May 2009, In : The oncologist. 14, 5, p. 548-556 9 p.

Research output: Contribution to journalArticle

Sinusal localization of nodal micrometastases is a prognostic factor in breast cancer

Masci, G., di Tommaso, L., del Prato, I., Orefice, S., Rubino, A., Gullo, G., Zuradelli, M., Sacco, R., Alloisio, M., Eboli, M., Incarbone, M., Giordano, L., Roncalli, M. & Santoro, A., Oct 29 2009, In : Annals of Oncology. 21, 6, p. 1228-1232 5 p.

Research output: Contribution to journalArticle

2008

A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancer

Santoro, A., Comandone, A., Rimassa, L., Granetti, C., Lorusso, V., Oliva, C., Ronzoni, M., Siena, S., Zuradelli, M., Mari, E., Pressiani, T. & Carnaghi, C., 2008, In : Annals of Oncology. 19, 11, p. 1888-1893 6 p.

Research output: Contribution to journalArticle

2007
2006